204 related articles for article (PubMed ID: 8763991)
1. Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals.
Yao QY; Tierney RJ; Croom-Carter D; Dukers D; Cooper GM; Ellis CJ; Rowe M; Rickinson AB
J Virol; 1996 Aug; 70(8):4884-94. PubMed ID: 8763991
[TBL] [Abstract][Full Text] [Related]
2. Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals.
Yao QY; Tierney RJ; Croom-Carter D; Cooper GM; Ellis CJ; Rowe M; Rickinson AB
J Virol; 1996 Aug; 70(8):4895-903. PubMed ID: 8763992
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of infection with Epstein-Barr virus types 1 and 2: lessons from the study of a T-cell-immunocompromised hemophilic cohort.
Yao QY; Croom-Carter DS; Tierney RJ; Habeshaw G; Wilde JT; Hill FG; Conlon C; Rickinson AB
J Virol; 1998 May; 72(5):4352-63. PubMed ID: 9557725
[TBL] [Abstract][Full Text] [Related]
4. The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers.
Yao QY; Rowe M; Martin B; Young LS; Rickinson AB
J Gen Virol; 1991 Jul; 72 ( Pt 7)():1579-90. PubMed ID: 1649896
[TBL] [Abstract][Full Text] [Related]
5. Oral EBV and KSHV infection in HIV.
Webster-Cyriaque J; Duus K; Cooper C; Duncan M
Adv Dent Res; 2006 Apr; 19(1):91-5. PubMed ID: 16672557
[TBL] [Abstract][Full Text] [Related]
6. Frequent presence of latent Epstein-Barr virus infection in peripheral T cell lymphomas. A review.
Anagnostopoulos I; Hummel M; Stein H
Leuk Lymphoma; 1995 Sep; 19(1-2):1-12. PubMed ID: 8574154
[TBL] [Abstract][Full Text] [Related]
7. Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children.
Ikuta K; Satoh Y; Hoshikawa Y; Sairenji T
Microbes Infect; 2000 Feb; 2(2):115-20. PubMed ID: 10742683
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-associated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events: a clinicopathologic and molecular analysis of 29 tumors from 19 patients.
Deyrup AT; Lee VK; Hill CE; Cheuk W; Toh HC; Kesavan S; Chan EW; Weiss SW
Am J Surg Pathol; 2006 Jan; 30(1):75-82. PubMed ID: 16330945
[TBL] [Abstract][Full Text] [Related]
9. Latent Epstein-Barr virus infection demonstrated in low-grade leiomyosarcomas of adults with acquired immunodeficiency syndrome, but not in adjacent Kaposi's lesion or smooth muscle tumors in immunocompetent patients.
Boman F; Gultekin H; Dickman PS
Arch Pathol Lab Med; 1997 Aug; 121(8):834-8. PubMed ID: 9278611
[TBL] [Abstract][Full Text] [Related]
10. Salivary and serum IgA antibodies to the Epstein-Barr virus glycoprotein gp340: incidence and potential for virus neutralization.
Yao QY; Rowe M; Morgan AJ; Sam CK; Prasad U; Dang H; Zeng Y; Rickinson AB
Int J Cancer; 1991 Apr; 48(1):45-50. PubMed ID: 1850382
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains.
Brooks JM; Croom-Carter DS; Leese AM; Tierney RJ; Habeshaw G; Rickinson AB
J Virol; 2000 Feb; 74(4):1801-9. PubMed ID: 10644353
[TBL] [Abstract][Full Text] [Related]
12. Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects.
Sculley TB; Apolloni A; Hurren L; Moss DJ; Cooper DA
J Infect Dis; 1990 Sep; 162(3):643-8. PubMed ID: 2167337
[TBL] [Abstract][Full Text] [Related]
13. Low incidence of Epstein-Barr virus presence in primary cutaneous T-cell lymphoproliferations.
Anagnostopoulos I; Hummel M; Kaudewitz P; Korbjuhn P; Leoncini L; Stein H
Br J Dermatol; 1996 Feb; 134(2):276-81. PubMed ID: 8746341
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan.
Higa M; Kinjo T; Kamiyama K; Iwamasa T; Hamada T; Iyama K
J Clin Pathol; 2002 Jun; 55(6):414-23. PubMed ID: 12037022
[TBL] [Abstract][Full Text] [Related]
15. Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes.
Apolloni A; Sculley TB
Virology; 1994 Aug; 202(2):978-81. PubMed ID: 8030259
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus infection in HIV-positive patients.
Telenti A; Uehlinger DE; Marchesi F; Germann D; Malinverni R; Matter L
Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):601-9. PubMed ID: 7901016
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus infection of HIV-seropositive individuals is transiently suppressed by high-dose acyclovir treatment.
Luxton JC; Williams I; Weller I; Crawford DH
AIDS; 1993 Oct; 7(10):1337-43. PubMed ID: 8267906
[TBL] [Abstract][Full Text] [Related]
18. Direct Epstein-Barr virus (EBV) typing on peripheral blood mononuclear cells: no association between EBV type 2 infection or superinfection and the development of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma.
van Baarle D; Hovenkamp E; Kersten MJ; Klein MR; Miedema F; van Oers MH
Blood; 1999 Jun; 93(11):3949-55. PubMed ID: 10339504
[TBL] [Abstract][Full Text] [Related]
19. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
[TBL] [Abstract][Full Text] [Related]
20. Genotypic and phenotypic alterations in Epstein-Barr virus-associated lymphoma.
Ohshima K; Suzumiya J; Kanda M; Haraoka S; Kawasaki C; Shimazaki K; Kikuchi M
Histopathology; 1999 Dec; 35(6):539-50. PubMed ID: 10583578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
